1. Home
  2. ABAT vs RCKT Comparison

ABAT vs RCKT Comparison

Compare ABAT & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Battery Technology Company

ABAT

American Battery Technology Company

HOLD

Current Price

$3.70

Market Cap

467.6M

ML Signal

HOLD

Logo Rocket Pharmaceuticals Inc.

RCKT

Rocket Pharmaceuticals Inc.

HOLD

Current Price

$4.96

Market Cap

428.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABAT
RCKT
Founded
2011
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
467.6M
428.6M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
ABAT
RCKT
Price
$3.70
$4.96
Analyst Decision
Buy
Analyst Count
0
14
Target Price
N/A
$30.42
AVG Volume (30 Days)
3.6M
2.2M
Earning Date
06-15-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
43.14
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$145.40
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.86
$2.19
52 Week High
$11.49
$9.35

Technical Indicators

Market Signals
Indicator
ABAT
RCKT
Relative Strength Index (RSI) 44.22 81.72
Support Level $3.56 $2.99
Resistance Level $3.89 $8.26
Average True Range (ATR) 0.22 0.29
MACD 0.00 0.18
Stochastic Oscillator 31.01 82.97

Price Performance

Historical Comparison
ABAT
RCKT

About ABAT American Battery Technology Company

American Battery Technology Co is an integrated critical battery minerals company that develops technologies for both primary battery minerals manufacturing and lithium-ion battery recycling. It operates battery recycling facilities that process materials from electric vehicle batteries, stationary battery energy storage systems, and consumer electronics. Additionally, the company advances lithium production projects using proprietary technology to produce battery-grade lithium hydroxide. It generates revenue mainly from its recycling operations and is expanding capacity with strategic partnerships and government grants. The company's activities focus on creating a closed-loop battery materials supply chain to support sustainable manufacturing in the United States.

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

Share on Social Networks: